Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:44 PM
Ignite Modification Date:
2025-12-24 @ 5:44 PM
NCT ID:
NCT01019668
Eligibility Criteria:
Inclusion Criteria:
* Patients with best-corrected visual acuity (BCVA) of 20/200 or better
* Presence of subretinal fluid (SRF) and/or serous pigment epithelial detachment (PED) involving the fovea on optical coherence tomography (OCT)
* Presence of active angiographic leakage in fluorescein angiography (FA) caused by CSC but not CNV or other diseases
* Abnormal dilated choroidal vasculature and other features in ICGA consistent with the diagnosis of CSC.
Exclusion Criteria:
* Patients who received previous PDT or focal thermal laser photocoagulation for the treatment of CSC.
* Patients had evidence of CNV, polypoidal choroidal vasculopathy, or other maculopathy on clinical examination, FA, or ICGA
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT01019668
Study Brief:
Protocol Section:
NCT01019668